Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block vs Paracetamol for Inguinal Hernia Repair
NCT05122351Phase 1Completed
- Sponsor
- Sohag University
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by Sohag University. Primary endpoint: Analgesia in Patients with Open Inguinal Hernia Surgeries at 6 months. Started Oct 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05122351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122351.